Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-03-21
1985-04-09
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514264, 514307, 514320, 514912, A61K 31485, A61K 3152, A61K 31445, A61K 31365
Patent
active
045101450
ABSTRACT:
Method for controlling the contraction of ophthalmic wounds or incisions by administering through an ophthalmalogically acceptable composition including a smooth muscle relaxant such as papavarine. The method also encompasses the administration to such wounds or incisions of a smooth muscle stimulant such as Seratonin.
REFERENCES:
patent: 2390555 (1945-12-01), Richardson
patent: 3910927 (1975-10-01), Kreighbaum et al.
patent: 4018927 (1977-04-01), Voorhees
Science 173 (996), pp. 548-550 (1971), Majro et al., "Contraction of Granulation Tissue .
Chem. Abst. 69, 103502(u) (1968), Bernat.
LandOfFree
Method for inhibiting contraction of ophthalmic wounds or incisi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inhibiting contraction of ophthalmic wounds or incisi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inhibiting contraction of ophthalmic wounds or incisi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1169233